Ruqi Wang's presentation will review the complexities involved in evaluating immunogenicity for cell and gene therapies. It will also provide valuable insights into the use of flow cytometry in ADA and NAb assays to assess humoral immune response. Additionally, the presentation will delve into crucial considerations for developing and validating these specific assays.